Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based studyAnnette Wigertz, Mats Lambe, Johan Ahlgren et al.|Breast Cancer Research and Treatment|2012Cited by 125
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast CancerLinda S. Lindström, Christina Yau, Kamila Czene et al.|JNCI Journal of the National Cancer Institute|2017Cited by 90
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifenJohan Rosell, John Carstensen, Bo Nordenskjöld et al.|Acta Oncologica|2017Cited by 32
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-upJohan Rosell, John Carstensen, Tommy� Fornander et al.|Breast Cancer Research and Treatment|2013Cited by 30
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER TrialAlexios Matikas, I. Thalmann, Volker Möbus et al.|Journal of Clinical Oncology|2024Cited by 11